Margin-enriched CD4+ central-memory T cells affect macrophages via ANXA1-FPR1 signaling axis to promote tumor progression in intrahepatic cholangiocarcinoma
Aug 2026· International Journal on Biological Sciences· Vol 22, pp. 7225 - 7239· 0 citations· 34 references
Medicine
TL;DR
This study systematically characterized the features and distribution of CD4+ ANXA1+ Tcm cells in the margin zone of iCCA and investigated the potential mechanisms by which CD4+ ANXA1+ Tcm cells affected tumor progression, providing novel understanding of the function of these CD4+ Tcm cells in iCCA.
Abstract
Intrahepatic cholangiocarcinoma (iCCA) is the second most prevalent liver cancer with a high mortality and recurrence rate, and remains a poorly understood disease. The tumor margin, as the transition zone between normal tissue and tumor, was not appreciated before. We performed mass cytometry (cytometry by time of flight, CyTOF) on 30 samples from iCCA tumor, paratumor and margin tissue. We found that the number of CD4+ central memory T cells (CD4+ Tcm) increased in the margin zone. Single cell RNA-seq (scRNA-seq) further discovered that CD4+ Tcm cells enriched in the margin zone of iCCA exhibited upregulated Annexin A1 (ANXA1) expression. Fibroblasts recruited CD4+ ANXA1+ Tcm cells via Chemokine (C-C motif) ligand 19 (CCL19)-Chemokine (C-C motif) receptor 7 (CCR7) signaling pathway. The molecular characteristics of CD4+ ANXA1+ Tcm in iCCA were characterized, and the interactions between these T cells and other cells were determined. Patients with enriched CD4+ ANXA1+ Tcm cells in the tumor margin exhibited a worse prognosis. Specifically, CD4+ ANXA1+ Tcm cells could recruit macrophages to the tumor margin and regulate the macrophage polarization via the ANXA1-Formyl Peptide Receptor 1 (FPR1) signaling axis. CD4+ ANXA1+ Tcm cell-activated macrophages could enhance the invasion and proliferation of tumor cells by exerting different cytokines. In conclusion, our study systematically characterized the features and distribution of CD4+ ANXA1+ Tcm cells in the margin zone of iCCA. We investigated the potential mechanisms by which CD4+ ANXA1+ Tcm cells affected tumor progression, and provided novel understanding of the function of these CD4+ Tcm cells in iCCA.
Background: Intrahepatic cholangiocarcinoma (ICC) is the second most common primary liver cancer. Macrophages are crucial components of the tumor microenvironment (TME). Triggering receptor expressed on myeloid cells 2-positive (TREM2+) macrophages have recently emerged as potent pro-tumor progress players in several c...
Yao Li, Hong-Wen Liu, Lei Xu et al.· Cancer Communications· 0 citations
Abstract Adrenocortical carcinoma (ACC) is a rare and highly aggressive endocrine malignancy with limited treatment options and poor prognosis. Venous tumor thrombus (VTT) is a common complication associated with ACC progression, yet the cellular and molecular mechanisms driving VTT formation remain largely unknown. We...
Hou-Liang Zhang, Kang-Jie Xu, Lan Zhen et al.· Journal for ImmunoTherapy of...· 0 citations
T-cell function is regulated by immunometabolism, and lysosomes are signaling hubs. CD68 (LAMP4), traditionally regarded as a monocyte/macrophage marker, has been largely neglected in T cell biology. We aimed to assess the link between CD68 expression in T cells and anti-PD-1 response in lung cancer, and its pote...
Ying Wang, Jing Huang, Zheng-Yi Sun et al.· Frontiers in Immunology· 0 citations
Abstract Background Checkpoint blockade (CPB) has limited efficacy in patients with colorectal cancer (CRC), warranting improved therapeutic strategies capable of remodeling the tumor microenvironment. Stem-like TCF1+CD8+ T cells, cytotoxic CD8+ T cells, and lymphoid aggregates have been associated with CPB responsiven...
C. Minnar, Masaya Miyamoto, Asma S. Khelifa et al.· Journal for ImmunoTherapy of...· 0 citations
This study delineates a novel CAF-driven immunosuppressive pathway in HCC, where CD147+ CAFs enhance tumor cell PD-L1 expression and susceptibility to immune checkpoint blockade via a TIMP2/MMP2/IL-6 axis.
Yi-Fei Wang, Bo-Wei Lv, Xiao-Jing Su et al.· Asia-Pacific Journal of Clin...· 0 citations
Intrahepatic cholangiocarcinoma (ICC) is a rare but highly aggressive primary liver malignancy distinguished by a profoundly heterogeneous tumor microenvironment, which underlies its limited response to targeted and immune-based therapies. Deciphering the cellular composition and intercellular signaling within this com...
Guo-Liang Wang, Hang Meng, Meng Li et al.· Genomics, Proteomics & Bioin...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.